ZA200600225B - Thienopyrimidine derivatives as potassium channel inhibitors - Google Patents

Thienopyrimidine derivatives as potassium channel inhibitors Download PDF

Info

Publication number
ZA200600225B
ZA200600225B ZA200600225A ZA200600225A ZA200600225B ZA 200600225 B ZA200600225 B ZA 200600225B ZA 200600225 A ZA200600225 A ZA 200600225A ZA 200600225 A ZA200600225 A ZA 200600225A ZA 200600225 B ZA200600225 B ZA 200600225B
Authority
ZA
South Africa
Prior art keywords
pyrimidin
thieno
phenyl
ylmethyl
pyridin
Prior art date
Application number
ZA200600225A
Other languages
English (en)
Inventor
Ford John
Atherall John Frederick
Brad Sherbone
Stevens Edward Benedict
Palmer Nicholas John
Magde David John
Bushfield Mark
Original Assignee
Xention Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0315950.6A external-priority patent/GB0315950D0/en
Application filed by Xention Discovery Ltd filed Critical Xention Discovery Ltd
Publication of ZA200600225B publication Critical patent/ZA200600225B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200600225A 2003-06-11 2006-01-10 Thienopyrimidine derivatives as potassium channel inhibitors ZA200600225B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47751803P 2003-06-11 2003-06-11
GBGB0315950.6A GB0315950D0 (en) 2003-06-11 2003-06-11 Compounds

Publications (1)

Publication Number Publication Date
ZA200600225B true ZA200600225B (en) 2007-04-25

Family

ID=33554173

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200600225A ZA200600225B (en) 2003-06-11 2006-01-10 Thienopyrimidine derivatives as potassium channel inhibitors

Country Status (16)

Country Link
EP (1) EP1641803B3 (xx)
KR (1) KR101186678B1 (xx)
CN (1) CN1823071B (xx)
AT (1) ATE425982T1 (xx)
AU (1) AU2004247470B2 (xx)
BR (1) BRPI0411239A (xx)
CA (1) CA2528848C (xx)
DE (1) DE602004020070D1 (xx)
DK (1) DK1641803T3 (xx)
ES (1) ES2324536T7 (xx)
HK (1) HK1093064A1 (xx)
MX (1) MXPA05013549A (xx)
PL (1) PL1641803T6 (xx)
SI (1) SI1641803T1 (xx)
WO (1) WO2004111057A1 (xx)
ZA (1) ZA200600225B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
CA2571857A1 (en) 2004-06-29 2006-01-12 Amgen Inc. Furanopyrimidines
KR101386797B1 (ko) * 2004-10-21 2014-04-21 다우 아그로사이언시즈 엘엘씨 살진균 활성을 갖는 티에노-피리미딘 화합물
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
US7576080B2 (en) * 2004-12-23 2009-08-18 Memory Pharmaceuticals Corporation Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
EP1922311A2 (en) 2005-09-09 2008-05-21 Brystol-Myers Squibb Company Acyclic ikur inhibitors
GB0525164D0 (en) * 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
US8883852B2 (en) 2008-10-22 2014-11-11 University of Pittburgh—Of the Commonwealth System of Higher Education Radioprotective agents
EP2923734B1 (en) 2009-03-13 2018-01-10 Katholieke Universiteit Leuven, K.U. Leuven R&D Purine analogues and their use as immunosuppressive agents
WO2011028741A1 (en) 2009-09-03 2011-03-10 Bristol-Myers Squibb Company Quinazolines as potassium ion channel inhibitors
AU2011216404B2 (en) * 2010-02-17 2016-04-07 Takeda Pharmaceutical Company Limited Heterocyclic compound
GB201012889D0 (en) 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
WO2012044993A1 (en) * 2010-09-30 2012-04-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
GB201105659D0 (en) * 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (xx) 2011-07-01 2018-04-28
WO2013072693A1 (en) * 2011-11-15 2013-05-23 Xention Limited Thieno [2, 3 - c] pyrazoles for use as potassium channel inhibitors
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
EP3048106B1 (en) 2011-11-23 2019-11-06 Cancer Research Technology Limited Thienopyrimidine as inhibitors of atypical protein kinase c
US20150045305A1 (en) 2012-01-27 2015-02-12 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases
EP2964654A4 (en) * 2013-03-07 2016-08-10 Glaxosmithkline Llc THIEN [3,2-D] PYRIMIDIN-6-CARBOXAMIDE AND ANALOGUE AS SIRTUIN MODULATORS
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD248593A1 (de) * 1985-01-11 1987-08-12 Univ Halle Wittenberg Verfahren zur herstellung von 4-basischsubstituierten thieno/2,3-d/pyrimidin-6-ylcarbonsaeureestern
WO2001046155A1 (en) * 1999-12-21 2001-06-28 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors

Also Published As

Publication number Publication date
CN1823071A (zh) 2006-08-23
KR20060057539A (ko) 2006-05-26
PL1641803T6 (pl) 2011-04-29
CA2528848C (en) 2012-09-04
WO2004111057A1 (en) 2004-12-23
EP1641803B1 (en) 2009-03-18
MXPA05013549A (es) 2006-04-05
BRPI0411239A (pt) 2006-07-18
DE602004020070D1 (de) 2010-10-07
CA2528848A1 (en) 2004-12-23
AU2004247470A1 (en) 2004-12-23
PL1641803T3 (pl) 2009-08-31
ES2324536T7 (es) 2012-03-16
KR101186678B1 (ko) 2012-09-27
EP1641803B3 (en) 2010-12-08
EP1641803A1 (en) 2006-04-05
CN1823071B (zh) 2012-12-19
AU2004247470B2 (en) 2009-04-23
SI1641803T1 (sl) 2009-08-31
ATE425982T1 (de) 2009-04-15
HK1093064A1 (en) 2007-02-23
ES2324536T3 (es) 2009-08-10
DK1641803T3 (da) 2009-06-29

Similar Documents

Publication Publication Date Title
ZA200600225B (en) Thienopyrimidine derivatives as potassium channel inhibitors
US8022076B2 (en) Substituted thieno[2,3-d]pyrimidines as potassium channel inhibitors
KR101507182B1 (ko) 포스포이노시타이드 3-키나제 억제제 화합물 및 그의 사용 방법
JP5096142B2 (ja) Vegfレセプターおよびhgfレセプターシグナル伝達の阻害剤
EP1701944B1 (en) 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases
KR101524337B1 (ko) Trpa1 조절자로서 티에노피리미딘디온 유도체
WO2009046416A1 (en) Anilinopyrimidines as jak kinase inhibitors
MX2008011525A (es) Inhibidores de mnk2 de 8-heteroarilpurina para el tratamiento de trastornos metabolicos.
JPH0776586A (ja) ピリジン化合物
AU2012235882B2 (en) Thieno [2, 3 -d] pyrimidine derivatives and their use to treat arrhythmia
NZ615621B2 (en) Thieno [2,3-d] pyrimidine derivatives and their use to treat arrhythmia
OA16730A (en) Thieno [2,3 -D] Pyrimidine derivatives and their use to treat Arrhythmia.